Distribution of study joints by treatment
| Joint . | FEIBA, no. (%) . | NovoSeven, no. (%) . |
|---|---|---|
| Knee | 15 (31.3) | 26 (54.2) |
| Elbow | 21 (43.8) | 10 (20.8) |
| Ankle | 10 (20.8) | 9 (18.8) |
| Elbow and knee | 0 (0.0) | 1 (2.1) |
| Ankle and knee | 0 (0.0) | 1 (2.1) |
| Shoulder | 1 (2.1) | 0 (0.0) |
| Hip | 1 (2.1) | 1 (2.1) |
| Joint . | FEIBA, no. (%) . | NovoSeven, no. (%) . |
|---|---|---|
| Knee | 15 (31.3) | 26 (54.2) |
| Elbow | 21 (43.8) | 10 (20.8) |
| Ankle | 10 (20.8) | 9 (18.8) |
| Elbow and knee | 0 (0.0) | 1 (2.1) |
| Ankle and knee | 0 (0.0) | 1 (2.1) |
| Shoulder | 1 (2.1) | 0 (0.0) |
| Hip | 1 (2.1) | 1 (2.1) |
For both the FEIBA and NovoSeven categories, N = 48.